Anteris Technologies GlobalASX:AVR +10.05%50 Gross Margin % is 76.85% as of Mar. 2026, which is 46% above its 10-year median of 52.74. GuruFocus rates ASX:AVR with a GF Score™ of 50/100. The stock has 7 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Anteris Technologies Global ranks better than 84.6% on this metric.
ASX:AVR's Gross Margin % is ranked better than 84.6% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ASX:AVR: 74.28
Anteris Technologies Global had a gross margin of 76.85% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Anteris Technologies Global (ASX:AVR) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Anteris Technologies Global had a gross margin of 76.85% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Anteris Technologies Global Gross Margin % Related Terms
Anteris Technologies Global Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AVR vs INMD, QDEL, SSII: Gross Margin % Comparison
For the Medical Devices subindustry, Anteris Technologies Global's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anteris Technologies Global Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Anteris Technologies Global's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Anteris Technologies Global (ASX:AVR) has a Gross Margin % of 76.85% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Anteris Technologies Global and its competitors. This is 46% above median its historical median of 52.74. Over the past decade, Anteris Technologies Global's Gross Margin % has ranged from 36.20 to 78.95. According to the industry distribution chart, Anteris Technologies Global ranks #124 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 15.4%.
Is Anteris Technologies Global's Gross Margin % too high?
Anteris Technologies Global's current Gross Margin % of 76.85% is 46% above median its 10-year median of 52.74. Over the past 10 years, this metric has ranged from a low of 36.20 to a high of 78.95. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Anteris Technologies Global's value of 76.85% is 47.6% above this industry median. Based on the distribution chart, Anteris Technologies Global ranks #124 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Anteris Technologies Global has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Anteris Technologies Global's Gross Margin % compare to INMD and QDEL?
According to the Medical Devices & Instruments industry distribution chart, Anteris Technologies Global ranks #124 out of 805 companies for Gross Margin %. This places Anteris Technologies Global in the top 15% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Anteris Technologies Global's value of 76.85% is 47.6% above this benchmark. Historically, Anteris Technologies Global's own Gross Margin % has ranged from 36.20 to 78.95 over the past decade. While the company's 10-year median is 52.74 vs. the industry median of 52.07, Anteris Technologies Global has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anteris Technologies Global's current Gross Margin % of 76.85% is 47.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Anteris Technologies Global and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anteris Technologies Global's current Gross Margin % is 76.85%, which is 46% above median its own 10-year median of 52.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anteris Technologies Global stock overvalued right now?
Anteris Technologies Global (ASX:AVR) has a current Gross Margin % of 76.85%. The current Gross Margin % is 76.85%, which is 46% above median its 10-year median of 52.74 and 47.6% above the Medical Devices & Instruments industry median of 52.07. Anteris Technologies Global's overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Anteris Technologies Global (ASX:AVR), the current Gross Margin % is 76.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
50GF Score
Get the complete analysis for ASX:AVR
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AVR has been successfully added to your 
